Moreover, TNBC patients with high CD8+T cell infiltration tended to show higher survival rates, and this correlation is absent in other BC subtypes, therefore, CD8+T cell score can be used as a prognostic biomarker for TNBC management (112). Here, CD8A is linked to breast cancer.